AHSG and Insulin resistance: Higher circulating levels of fetuin-A can affect obesity, metabolic syndrome, and insulin resistance/T2D (12), and fetuin A has roles in the development of T2DM, metabolic disorders, NAFLD, cardiovascular diseases (CVD), some types of cancers, and some brain disorders (13).